Filing Details
- Accession Number:
- 0001209191-11-043603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-11 10:15:03
- Reporting Period:
- 2011-08-09
- Filing Date:
- 2011-08-11
- Accepted Time:
- 2011-08-11 10:15:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1000694 | Novavax Inc | NVAX | Biological Products, (No Disgnostic Substances) (2836) | 222816046 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1342826 | C Stanley Erck | C/O 9920 Belward Campus Drive Rockville MD 20850 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-09 | 33,448 | $1.24 | 33,448 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-08-10 | 16,552 | $1.24 | 16,552 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |